Serge Saxonov - 21 Mar 2023 Form 4 Insider Report for 10x Genomics, Inc. (TXG)

Role: Chief Executive Officer, Director
Signature: /s/ Eric S. Whitaker, as Attorney-in-Fact for Serge Saxonov
Issuer symbol: TXG
Transactions as of: 21 Mar 2023
Net transactions value: $0
Form type: 4
Filing time: 23 Mar 2023, 18:25:43 UTC
Previous filing: 16 Mar 2023
Next filing: 18 Apr 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TXG	Class A Common Stock	Award	$0	+36,387	+4.2%	$0.000000	899,792	21 Mar 2023	Direct	F1
holding	TXG	Class A Common Stock						870	21 Mar 2023	See footnote	F2
holding	TXG	Class A Common Stock						183,350	21 Mar 2023	See footnote	F3
holding	TXG	Class A Common Stock						16,320	21 Mar 2023	See footnote	F4
holding	TXG	Class A Common Stock						487	21 Mar 2023	See footnote	F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TXG	Stock Option (right to buy)	Award	$0	+72,773		$0.000000	72,773	21 Mar 2023	Class A Common Stock	72,773	$50.10	Direct	F6
transaction	TXG	Performance - based Restricted Stock Units	Award	$0	+72,773		$0.000000	72,773	21 Mar 2023	Class A Common Stock	72,773		Direct	F7

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Constitute restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/16th of the RSUs shall vest on each quarterly anniversary measured from February 21, 2023, subject to the Reporting Person continuing as a service provider through each such date.
F2	The shares are held by the Sirius Trust, for which the Reporting Person serves as trustee.
F3	The shares are held by the Y/S Descendants' Trust, for which the Reporting Person serves as trustee.
F4	The shares are held by the Y/S Pot Trust, for which the Reporting Person serves as trustee.
F5	The shares are held by the Andromeda Trust, for which the Reporting Person serves as trustee.
F6	1/48th of the total number of shares subject to the option vest on each monthly anniversary measured from April 1, 2023, subject to the Reporting Person continuing as a service provider through each such date.
F7	Each Performance-Based Restricted Stock Unit ("PSU") represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/3rd of the PSUs shall vest upon the Issuer's Class A Common Stock achieving each of three escalating stock price milestones, subject to the Reporting Person continuing as a service provider through each such date.